|
WO2018015054A1
|
|
A thermogelling supramolecular sponge as self-healing and biocompatible hydrogel
|
|
AU2016333538A1
|
|
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
|
|
EP3284801A1
|
|
Ligands, electrochromic metallo-polymers obtained therewith and their use
|
|
DE102016009766A1
|
|
Production of bitter substance derivatives
|
|
EP3266465A1
|
|
Immune complexes
|
|
WO2016174104A1
|
|
Modified bacterial nanocellulose and its uses in chip cards and medicine
|
|
DE102016205474A1
|
|
Dexpanthenol containing compound
|
|
DE102016001344A1
|
|
Process for the preparation of potassium monofluorotricyanoborate
|
|
EP3184149A1
|
|
Soluble glycoprotein v for treating thrombotic diseases
|
|
EP3184544A1
|
|
Glycoprotein v inhibitors for use as coagulants
|
|
DE102015016400A1
|
|
Process for the preparation of salts with Perfluoralkyltricyanoboratanionen or Tetracyanoboratanionen
|
|
DE102015016401A1
|
|
Process for the preparation of salts with monofluorotricyanoborate anions
|
|
DE102015224054A1
|
|
Modified TrueFISP sequence for parallel MR data acquisition
|
|
DE102015114956A1
|
|
Apparatus and method for mass collecting samples
|
|
DE102015109678A1
|
|
Dynamic Fourier-space magnetic resonance
|
|
DE102015006493A1
|
|
Polymers comprising polymerized ionic liquids and their use in membranes
|
|
DE102014018103A1
|
|
Process for the preparation of compounds with tricyanoborate dianions
|
|
DE102014016681A1
|
|
Process for the preparation of salts with hydridocyanoborate anions
|
|
DE102014016583A1
|
|
Process for the preparation of perfluoroalkyl fluoroborate salts
|
|
DE102011086421A1
|
|
Device for bite protection
|
